Urology
Volume 69, Issue 3 , Pages 526-531 , March 2007

Phase II Study of Imatinib Mesylate in Patients with Prostate Cancer with Evidence of Biochemical Relapse After Definitive Radical Retropubic Prostatectomy or Radiotherapy

  • Gopal K. Bajaj

      Affiliations

    • Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • ,
  • Zhe Zhang

      Affiliations

    • Department of Oncology Biostatistics, Johns Hopkins Hospital, Baltimore, Maryland
  • ,
  • Elizabeth Garrett-Mayer

      Affiliations

    • Department of Oncology Biostatistics, Johns Hopkins Hospital, Baltimore, Maryland
  • ,
  • Renee Drew

      Affiliations

    • Department of Radiation Oncology, Johns Hopkins Hospital, Baltimore, Maryland
  • ,
  • Victoria Sinibaldi

      Affiliations

    • Department of Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, Maryland
  • ,
  • Roberto Pili

      Affiliations

    • Department of Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, Maryland
  • ,
  • Samuel R. Denmeade

      Affiliations

    • Department of Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, Maryland
  • ,
  • Michael A. Carducci

      Affiliations

    • Department of Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, Maryland
  • ,
  • Mario A. Eisenberger

      Affiliations

    • Department of Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, Maryland
  • ,
  • Theodore L. DeWeese

      Affiliations

    • Department of Radiation Oncology, Johns Hopkins Hospital, Baltimore, Maryland
    • Corresponding Author InformationReprint requests: Theodore L. DeWeese, M.D., Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Hospital, 401 North Broadway, Suite 1440, Weinberg, Baltimore, MD 21231.

Received 31 March 2006 ,Accepted 11 December 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(06)02630-6

doi: 10.1016/j.urology.2006.12.006

Urology
Volume 69, Issue 3 , Pages 526-531 , March 2007